Dr. Reddy's Laboratories Statistics

Total Valuation

Dr. Reddy's Laboratories has a market cap or net worth of INR 1.02 trillion. The enterprise value is 1.02 trillion.

Market Cap	1.02T
Enterprise Value	1.02T

Important Dates

The last earnings date was Thursday, January 23, 2025.

Earnings Date	Jan 23, 2025
Ex-Dividend Date	Jul 16, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	595.84M

Valuation Ratios

The trailing PE ratio is 19.01.

PE Ratio	19.01
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.68, with an EV/FCF ratio of 93.44.

EV / Earnings	18.92
EV / Sales	3.26
EV / EBITDA	11.68
EV / EBIT	14.36
EV / FCF	93.44

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.16.

Current Ratio	1.92
Quick Ratio	1.18
Debt / Equity	0.16
Debt / EBITDA	0.59
Debt / FCF	4.70
Interest Coverage	25.48

Financial Efficiency

Return on equity (ROE) is 18.47% and return on invested capital (ROIC) is 13.34%.

Return on Equity (ROE)	18.47%
Return on Assets (ROA)	10.32%
Return on Capital (ROIC)	13.34%
Revenue Per Employee	11.51M
Profits Per Employee	1.98M
Employee Count	27,048
Asset Turnover	0.73
Inventory Turnover	1.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.62% in the last 52 weeks. The beta is 0.33, so Dr. Reddy's Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+13.62%
50-Day Moving Average	1,285.32
200-Day Moving Average	1,287.82
Relative Strength Index (RSI)	29.16
Average Volume (20 Days)	1,898,093

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Reddy's Laboratories had revenue of INR 311.31 billion and earned 53.68 billion in profits. Earnings per share was 64.35.

Revenue	311.31B
Gross Profit	184.65B
Operating Income	70.49B
Pretax Income	72.75B
Net Income	53.68B
EBITDA	85.56B
EBIT	70.49B
Earnings Per Share (EPS)	64.35

Full Income Statement

Balance Sheet

The company has 59.92 billion in cash and 51.09 billion in debt, giving a net cash position of 8.84 billion.

Cash & Cash Equivalents	59.92B
Total Debt	51.09B
Net Cash	8.84B
Net Cash Per Share	n/a
Equity (Book Value)	321.57B
Book Value Per Share	381.36
Working Capital	121.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 35.95 billion and capital expenditures -25.09 billion, giving a free cash flow of 10.87 billion.

Operating Cash Flow	35.95B
Capital Expenditures	-25.09B
Free Cash Flow	10.87B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.31%, with operating and profit margins of 22.64% and 17.24%.

Gross Margin	59.31%
Operating Margin	22.64%
Pretax Margin	23.37%
Profit Margin	17.24%
EBITDA Margin	27.48%
EBIT Margin	22.64%
FCF Margin	3.49%

Dividends & Yields

Dr. Reddy's Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	12.41%
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	5.26%
FCF Yield	1.06%

Dividend Details

Stock Splits

The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Oct 28, 2024
Split Type	Forward
Split Ratio	5

Scores

Dr. Reddy's Laboratories has an Altman Z-Score of 6.27.

Altman Z-Score	6.27
Piotroski F-Score	n/a